Mirum Pharmaceuticals, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
MIRM Nasdaq 2834 www.mirumpharma.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Mirum Pharmaceuticals, Inc.

Insmed Catapults 34%, Leading A Biotech Rally. But Mirum Takes A Bath. - Aug 6th, 2026 2:12 pm
Mirum's Q2 Earnings Lag Estimates, Revenues Beat, 2026 View Raised - Aug 6th, 2026 9:21 am
Citizens Says FDA’s 'Unexpected' Phase 3 Request Clouds Mirum’s Near-Term Outlook – MIRM Stock Crashes 15% - Aug 6th, 2026 7:46 am
Mirum Pharmaceuticals Q2 Earnings Call Highlights - Aug 5th, 2026 9:03 pm
Mirum Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Aug 5th, 2026 8:02 pm
Compared to Estimates, Mirum Pharmaceuticals (MIRM) Q2 Earnings: A Look at Key Metrics - Aug 5th, 2026 4:00 pm
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Beats Revenue Estimates - Aug 5th, 2026 3:25 pm
Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update - Aug 5th, 2026 2:01 pm
Mirum Pharmaceuticals to Announce Second Quarter 2026 Financial Results and Host Conference Call on August 5, 2026 - Jul 29th, 2026 2:01 pm
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Jul 13th, 2026 2:01 pm
Stocks To Watch: 14 Names Test And Tease New Buy Zones - Jul 8th, 2026 2:10 pm
The Bull Case For Mirum Pharmaceuticals (MIRM) Could Change Following Priority FDA Review Of FOP Drug Zilurgisertib - Jul 2nd, 2026 3:14 am
Strength Seen in Mirum Pharmaceuticals (MIRM): Can Its 5.5% Jump Turn into More Strength? - Jun 29th, 2026 8:52 am
Is Mirum Pharmaceuticals, Inc. (MIRM) Emerging as a Rare Disease Growth Story After New FOP Data? - Jun 25th, 2026 6:41 am
MIRM, INCY Report Positive Rare Disease Data as FDA Begins NDA Review - Jun 15th, 2026 8:43 am
Why Is Mirum Pharmaceuticals (MIRM) Down 10.1% Since Last Earnings Report? - Jun 5th, 2026 9:30 am
Mirum Pharmaceuticals (MIRM) Reports Positive Phase 2b Data for Volixibat in PSC at EASL Congress - Jun 4th, 2026 3:06 am